Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute

Journal Article Accepted manuscript Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute Get access Navaneeth Narayanan, Navaneeth Narayanan Department of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA Corresponding author: Navaneeth Narayanan, PharmD, MPH, Rutgers University Ernest Mario School of Pharmacy, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, Email: navan12@pharmacy.rutgers.edu https://orcid.org/0000-0001-5071-9193 Search for other works by this author on: Oxford Academic PubMed Google Scholar Amy J Mathers, Amy J Mathers Department of Medicine and Pathology, University of Virginia, Charlottesville, Virginia, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Eric Wenzler, Eric Wenzler Roche Diagnostics Corporation, Indianapolis, IN, USA https://orcid.org/0000-0003-3914-8400 Search for other works by this author on: Oxford Academic PubMed Google Scholar Nicholas M Moore, Nicholas M Moore Departments of Internal Medicine and Pathology, Rush University Medical Center, Chicago, Illinois, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Christian G Giske, Christian G Giske Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden Search for other works by this author on: Oxford Academic PubMed Google Scholar Rodrigo E Mendes, Rodrigo E Mendes JMI Laboratories, North Liberty, Iowa, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Paul H Edelstein Paul H Edelstein Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USAMolecular Immunity Unit, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, Department of Medicine, University of Cambridge, Cambridge, UK https://orcid.org/0000-0002-4069-5279 Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae246, https://doi.org/10.1093/cid/ciae246 Published: 06 May 2024 Article history Received: 24 January 2024 Revision received: 16 April 2024 Accepted: 02 May 2024 Published: 06 May 2024